Cancer survivors face the possibility that cancer will come back after treatment. Clinical trials are studies that help researchers learn more to help slow, manage, and treat cancer, as well as prevent cancer recurrence. If you have had bladder cancer, you can volunteer for a bladder cancer prevention clinical trial that is studying encapsulated rapamycin (eRapa) and its ability to reduce the risk of bladder cancer recurrence. This trial is led by researchers across Texas, including UT Health San Antonio, UT Southwestern Medical Center, and South Texas Veterans Health Care System, to explore new ways to prevent bladder cancer from coming back. “Unfortunately, people who’ve had bladder cancer have a high risk of developing a second bladder cancer,” said Dr. Amelie ...
Cancer and Alzheimer’s hurt many of our abuelos, moms, dads, and others we love. Clinical trials help us fight for our familia. Clinical trials are studies that help researchers learn more to help slow, manage, and treat Alzheimer’s and cancer for current and future family members. But without Latino volunteers for clinical trials, the benefits may miss this group. Visit our clinical trials page to find a clinical trial, read about hero volunteers, and more! Share your story with us! “Latinos in clinical trials are not only helping themselves, but they’re also building a future with better treatments that can help their families in the future,” said Dr. Amelie Ramirez, director of the Institute for Health Promotion Research and Salud America! at UT Health San ...
When it comes to triple negative breast cancer, Ricki Fairley is a veteran on the battlefield. “I am a 10-year survivor of triple negative breast cancer. My doctor gave me two years to live, and I'm on 10,” Fairley said. Fairley is the CEO and co-founder of TOUCH—the Black Breast Cancer Alliance. She is determined to diversify clinical trials, which can help find better therapies for Black, Latino, and other people of color. “I'm really on a path, a mission to eradicate Black breast cancer and really change the game on how we talk to Black women about clinical trials. And right now, we only have 3% participation in clinical trials. So, the drugs that are currently on the market and the ...
Each year, more than 14,000 people are diagnosed with cervical cancer in the United States. This cancer is especially hurting communities of color, with Latinas at a high risk of a diagnosis. But cervical cancer is preventable. Stopping cervical cancer for Latinas and all communities means equitable education about the causes, prevention, and treatment of HPV and cervical cancer. Join #SaludTues at 1 p.m. EST on Jan. 4, 2022, to tweet about how we can stop cervical cancer in celebration of Cervical Cancer Awareness Month in January. WHAT: #SaludTues Tweetchat: “What Can We Do to Stop Cervical Cancer?”
DATE: Tuesday, Jan. 4, 2022
TIME: 1:00-2:00 p.m. EST (10:00-11:00 p.m. PST)
WHERE: On Twitter with hashtag #SaludTues
HOST: @SaludAmerica
CO-HOSTS: ...
While some cancers develop through unhealthy habits like smoking, others happen through genetics. Clinical trials with volunteers who have a family history of cancer can help researchers learn how to better slow, manage, and/or treat these diseases. This can help save the lives of people whose family experiences cancer generationally. If you have a family history of cancer, you can join a clinical trial at UT Health San Antonio that is studying pheochromocytomas and paragangliomas — endocrine tumors often inherited from family members genetically. “A family history of endocrine tumors could mean you and your loved ones have a higher risk,” said Dr. Amelie Ramirez, director of the Institute for Health Promotion Research and the Salud America! program at UT Health San ...
For Latino men, prostate cancer is the most common cancer diagnosis. While there is good news—from 2014-2018, Latino men were 20% less likely to face a prostate cancer diagnosis than their white peers—Latino men are more likely than their white peers to be diagnosed at a younger age, and with a higher risk of disease. This is why researchers at UT Health San Antonio are conducting the Prostate Active Surveillance Study (PASS) Clinical Trial in partnership with the Canary Foundation, a nonprofit dedicated to the early detection of cancer. The study is for men age 21 and older who have chosen active surveillance as a management plan for their prostate cancer. Active surveillance is defined as close monitoring of prostate cancer with the offer of treatment if there are changes ...
Latinos represent 18.5% of the U.S. population, but are far less than 10% of those in federal cancer and drug studies. This makes it hard for researchers to create treatments that work best for Latinos. To address this issue, you’re invited to join us for “How to Encourage Latinos to Participate in Clinical Trials,” the first webinar of a new series, “Let’s Address Health Equity Together,” at 11 a.m. CST on Dec. 14, 2021. This Zoom webinar will help health care professionals understand the lack of Latino participation in clinical trials and explore strategies and system-changing advocacy actions to improve Latino enrollment in clinical trials. "This webinar will help doctors, nurses, researchers and other healthcare professionals take action for diversifying ...
Medicine, radiation, chemotherapy, and surgery are common ways to treat breast cancer. Researchers are also exploring new, possibly better treatments and procedures in breast cancer clinical trials, which are carefully controlled research studies. In some cases, clinical trials may be the only way to get access to newer treatments. If you have breast cancer, you can find a new option for treatment by volunteering for the Evaluation of Cryotherapy and TRPA1 Receptors in Chemotherapy Induced Neuropathy at Mays Cancer Center at UT Health San Antonio. Cryotherapy uses extreme cold to freeze and kill cancer cells and control pain. The trial, for women ages 18 and older, including Latinas, aims to better treat women who are suffering at the hands of breast cancer. “It’s ...
Did you know that every 65 seconds, someone develops Alzheimer’s disease? This number is most troubling for Latinos and women. Latinos overall are 1.5 times more likely to develop Alzheimer’s than their White peers. Two-thirds of Alzheimer’s patients are women. Latinas are at higher risk than non-Latinas. In response, the federal government created a website, Alzheimers.gov, for dementia information, resources, and clinical trials. Now that website is also in Spanish at Alzheimers.gov/es! Each website has: Information about Alzheimer’s disease and related dementias, including causes, symptoms, diagnosis, and treatment.
Knowledge and resources for caregivers and people living with dementia.
Clinical trials and studies that people can join to help advance ...
